LMY-920 is an autologous CAR-T cell therapy expressing the BAFF-ligand.
| SparkCures ID | 453 |
|---|---|
| Generic Name | LMY-920 |
| Treatment Classifications | |
| Tags |
|
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.